Molecular and Genetic Analysis of Lung Cancer
NCT03029325 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000
Last updated 2024-11-29
Summary
Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.
Conditions
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
David C Christiani, MD · Harvard TH Chan School of Public Health
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1993-06-30
- Primary Completion
- 2026-09-30
- Completion
- 2026-09-30
Countries
- United States
Study Locations
More Related Trials
-
Cancer Panel From Blood of Lung Cancer Patients
NCT03235765 ·Status: UNKNOWN
-
Identification of a Plasma Proteomic Signature for Lung Cancer
NCT01752101 ·Status: COMPLETED
-
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
NCT01414595 ·Status: COMPLETED
-
A Prognosis and Predicting Genetic Study of Lung Cancer
NCT03234179 ·Status: NOT_YET_RECRUITING
-
Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.
NCT03220230 ·Status: COMPLETED
-
Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients
NCT02696525 ·Status: UNKNOWN
-
Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program
NCT03628638 ·Status: COMPLETED
-
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
NCT02715102 ·Status: TERMINATED
-
Incidence and Characterization of Drivers Oncogenes in the Population With Lung Cancer Afferents to the Cancer Institute in Aviano (IN.ON.D.)
NCT06180005 ·Status: RECRUITING
-
Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants
NCT00899457 ·Status: COMPLETED
-
Usefulness of Blood Biomarkers for Overall Survival in NSCLC
NCT01936571 ·Status: COMPLETED
-
Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment
NCT03244904 ·Status: UNKNOWN
-
Metabolomics Predict Therapy Response
NCT03736993 ·Status: COMPLETED ·Phase: NA
-
Analysis of Screen-detected Lung Cancers' Genomic Traits
NCT04204499 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarker Discovery and Validation in Lung Cancer
NCT01147562 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
NCT05265429 ·Status: RECRUITING
-
Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
NCT05794529 ·Status: RECRUITING
-
Genotyping of Non-small Cell Lung Cancer
NCT02002117 ·Status: UNKNOWN
-
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
NCT00899028 ·Status: COMPLETED
-
GWAS Research of Lung Cancer in Tianjin
NCT01255059 ·Status: UNKNOWN
-
Lung Cancer Risk Assessment and Etiology
NCT06328621 ·Status: COMPLETED
-
Machine Learning to Construct an Association Model for Lung Cancer and Environmental Hormone
NCT06259461 ·Status: ACTIVE_NOT_RECRUITING
-
Comparison of Circulating Tumor DNA and Tumor Tissue DNA by Targeted Sequencing in Non-Small Cell Lung Cancer
NCT02645318 ·Status: COMPLETED
-
Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment
NCT05627674 ·Status: ENROLLING_BY_INVITATION ·Phase: NA